Eve Air Mobility Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Eve Air Mobility Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||
net income | -64,686,000 | -48,784,000 | -40,696,000 | -35,788,000 | -36,388,000 | -25,296,000 | -39,266,146 | -31,209,846 | -31,410,026 | -25,771,982 | -20,054,063 | -132,693,936 | -26,679,139 | 5,396,780 | -3,400,064 |
adjustments to reconcile net income to net cash used by operating activities | |||||||||||||||
depreciation and amortization | 107,000 | 82,000 | 67,000 | 58,000 | 51,000 | ||||||||||
non-cash lease expenses | 165,000 | 172,000 | 154,000 | 279,000 | 33,000 | 54,000 | 29,234 | 21,056 | 24,249 | 9,461 | |||||
unrealized gain on exchange rate changes | |||||||||||||||
share-based compensation | 2,137,000 | 1,002,000 | 929,000 | 1,044,000 | 600,000 | 1,126,000 | -28,330 | 1,515,208 | |||||||
change in fair value of derivative financial instruments | 9,471,000 | -3,315,000 | 5,415,000 | -3,990,000 | -2,067,000 | -6,341,000 | 570,500 | 853,575 | |||||||
changes in operating assets and liabilities | |||||||||||||||
accrued interest on financial investments | -1,108,000 | -84,000 | 1,246,000 | -3,024,000 | -519,000 | -1,497,000 | 6,230,936 | -1,666,159 | |||||||
accrued interest on related party loan receivable | 0 | 4,487,000 | -1,223,000 | -1,222,000 | -1,235,425 | 2,835,878 | |||||||||
other assets | -470,000 | -1,346,000 | -2,848,000 | 1,021,000 | -1,235,000 | -1,285,000 | 1,355,745 | -753,152 | -695,211 | 715,618 | 1,548,970 | 3,444,864 | |||
related party receivables | -36,000 | 504,000 | -445,000 | -381,000 | 338,000 | 206,000 | 1,599,477 | -1,789,148 | -114,675 | 5,346 | 1,647 | ||||
accounts payable | 1,505,000 | -529,000 | -2,741,000 | 1,132,000 | 1,208,000 | -2,909,000 | 2,716,735 | -458,357 | 1,910,089 | -1,708,467 | -879,516 | 2,073,413 | |||
related party payables | -11,991,000 | 17,748,000 | 4,190,000 | 5,281,000 | 4,915,000 | 1,319,000 | -505,787 | 2,941,248 | 1,477,366 | 3,597,173 | -1,769,097 | ||||
other payables | 7,927,000 | 8,790,000 | -1,763,000 | -1,804,000 | 5,382,000 | 296,000 | 3,020,266 | 5,325,623 | -4,177,190 | 3,495,301 | 2,757,043 | 2,924,331 | |||
net cash used by operating activities | -55,645,000 | -24,878,000 | -38,676,000 | -30,722,000 | -30,755,000 | -35,813,000 | -24,512,468 | -22,392,696 | |||||||
cash flows from investing activities | |||||||||||||||
redemptions of financial investments | 38,000,000 | 117,000,000 | 77,000,000 | 13,000,000 | 37,000,000 | 10,000,000 | 147,000,000 | 15,000,000 | |||||||
purchases of financial investments | -10,000,000 | -98,000,000 | -70,000,000 | -172,000,000 | -15,000,000 | -12,000,000 | -100,000,000 | -27,000,000 | |||||||
expenditures for property | -1,258,000 | -464,000 | |||||||||||||
net cash from investing activities | -17,543,699 | -8,057,744 | -2,300,000 | ||||||||||||
cash flows from financing activities | |||||||||||||||
proceeds from issuance of debt | 14,077,615 | ||||||||||||||
non-creditor debt issuance costs | 0 | -178,000 | -297,000 | -296,000 | -272,000 | -219,000 | 132,201 | ||||||||
tax withholding on share-based compensation | 154 | 0 | |||||||||||||
net cash from financing activities | 11,202,000 | 9,277,000 | 65,245,000 | 14,747,000 | 14,211,820 | 0 | 23,579,719 | 328,973,832 | 150,000 | 2,300,000 | |||||
effect of exchange rate changes on cash and cash equivalents | -274,000 | 209,000 | -562,000 | -13,000 | -657,000 | -122,000 | 85,337 | -100,415 | 376,126 | 125,952 | |||||
decrease in cash and cash equivalents | -3,191,000 | 4,175,000 | -23,294,000 | 21,754,578 | -37,308,870 | ||||||||||
cash and cash equivalents at beginning of period | |||||||||||||||
cash and cash equivalents at end of period | |||||||||||||||
supplemental disclosure of cash information | |||||||||||||||
cash paid for | |||||||||||||||
interest | 2,241,000 | 2,088,000 | 1,522,000 | 597,000 | 447,000 | 273,000 | |||||||||
income tax | 643,000 | 372,000 | 1,009,000 | 804,000 | 949,000 | ||||||||||
supplemental disclosure of other non-cash investing and financing activities | |||||||||||||||
property expenditures in accounts payable and other payables | 150,000 | 441,000 | |||||||||||||
right-of-use assets obtained in exchange for operating lease liabilities | -6,000 | 16,000 | -10,000 | 502,000 | 52,000 | 564,000 | |||||||||
issuance of common stock for vested restricted stock units | 0 | 0 | 837,000 | 41,000 | 250 | ||||||||||
unrealized gain on the exchange rate changes | 981,000 | 953,000 | -1,858,000 | -315,000 | |||||||||||
deferred income tax | -99,000 | ||||||||||||||
net cash provided (used) by investing activities | 18,536,000 | 47,000,056 | -12,002,676 | ||||||||||||
proceeds from debt | 9,455,000 | 15,762,000 | 14,518,000 | 14,966,000 | |||||||||||
increase in cash and cash equivalents | 3,144,000 | -28,795,308 | -98,375,182 | ||||||||||||
cash and cash equivalents at the beginning of the period | 56,366,000 | 0 | 0 | 0 | 46,882,000 | -63 | 0 | 0 | 49,146,063 | 0 | 0 | ||||
cash and cash equivalents at the end of the period | 59,510,000 | 31,794,000 | -3,191,000 | 4,175,000 | 23,588,000 | 36,784,682 | -23,494,453 | 21,754,578 | 11,837,193 | -28,795,308 | -98,375,183 | ||||
depreciation, amortization, and loss on disposal | |||||||||||||||
unrealized (gain)/loss on exchange rate changes | |||||||||||||||
warrant expenses | 1,863,000 | 0 | |||||||||||||
deferred income taxes | |||||||||||||||
non-cash tax expense | |||||||||||||||
related party loan collected | |||||||||||||||
expenditures for property, plant and equipment | -1,215,000 | -3,236,000 | -659,000 | -106,000 | 56 | -2,676 | |||||||||
net cash (used) provided by investing activities | 5,785,000 | ||||||||||||||
proceeds from issuance of common stock, net of fees to investors | 0 | ||||||||||||||
non-investor equity issuance costs | 25,000 | ||||||||||||||
capital contribution net of transaction costs reimbursed to zanite | |||||||||||||||
transaction costs reimbursed to parent | 0 | ||||||||||||||
distribution to parent | |||||||||||||||
proceeds from exercised warrants | 0 | ||||||||||||||
net increase in cash and cash equivalents | |||||||||||||||
income taxes | 887,190 | ||||||||||||||
property, plant & equipment expenditures in accounts payable and other payables | |||||||||||||||
collection of related party loan | |||||||||||||||
property, plant & equipment expenditures in accounts payable and other accruals | -731,000 | 764,000 | 8,000 | 121,047 | |||||||||||
net cash provided (used) by financing activities | |||||||||||||||
net cash used by investing activities | -2,106,000 | ||||||||||||||
long-term incentive plan expense | 98,321 | 191,465 | 62,211 | ||||||||||||
related party loan | 0 | ||||||||||||||
transfer from parent | |||||||||||||||
recognition of the operating lease right-of-use assets and liabilities | |||||||||||||||
additions to capitalized software transferred by parent | |||||||||||||||
cash flows from operating activities: | |||||||||||||||
adjustments to reconcile net income to net cash used by operating activities: | |||||||||||||||
depreciation and loss on disposal of property | 38,581 | ||||||||||||||
amortization of debt issuance costs | |||||||||||||||
unrealized (gain) on exchange rate translation | |||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||
cash flows from investing activities: | |||||||||||||||
cash flows from financing activities: | |||||||||||||||
proceeds from exercise of public warrants | |||||||||||||||
cash paid for: | |||||||||||||||
recognition of the right-of-use assets and operating lease liabilities | |||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||
unrealized gain on exchange rate translation | |||||||||||||||
income tax paid | 240,228 | 147,665 | 1,459,843 | ||||||||||||
recognition of right-of-use assets and operating lease liabilities | |||||||||||||||
issuance of common stock for vested rsus | |||||||||||||||
depreciation | 22,050 | ||||||||||||||
unrealized loss/(gain) on the exchange rate translation | -58,553 | ||||||||||||||
stock-based compensation | 867,893 | 711,704 | |||||||||||||
warrants expenses | 2,674,500 | -1,830,866 | |||||||||||||
interest on financial investments | -3,828,323 | -1,527,542 | |||||||||||||
carve-out expenses | |||||||||||||||
operating lease liabilities | -9,461 | ||||||||||||||
net cash from operating activities | -19,891,123 | -20,737,564 | -25,536,180 | -12,583,141 | -600,661 | -599,069 | |||||||||
capex | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
free cash flows | -19,891,123 | -20,737,564 | -25,536,180 | -12,583,141 | -600,661 | -599,069 | |||||||||
purchases of investment securities | -17,500,000 | -8,000,000 | |||||||||||||
property, plant & equipment | -43,699 | -57,744 | |||||||||||||
supplemental disclosure of other non-cash investing activities | |||||||||||||||
f-5 | |||||||||||||||
amortization of capitalized software | |||||||||||||||
non-cash lease expenses - amortization & interest | |||||||||||||||
unrealized gains on financial investments | |||||||||||||||
supplemental disclosure of other noncash investing and income taxes paid | |||||||||||||||
recognition of the operating assets rou assets | |||||||||||||||
recognition of the operating lease liabilities | |||||||||||||||
gross capital contribution | -7,178,840 | ||||||||||||||
deemed distribution | |||||||||||||||
stock based compensation | |||||||||||||||
private warrants - change in fv | |||||||||||||||
related party receivable | |||||||||||||||
related party payable | |||||||||||||||
purchases of investing securities | |||||||||||||||
net cash from investing activities: | |||||||||||||||
transaction costs | |||||||||||||||
supplemental disclosure of other noncash investing and financing activities | |||||||||||||||
change in fair value of derivative liabilities | -6,952,500 | ||||||||||||||
interest earned on investments held in trust account | -21,121 | ||||||||||||||
prepaid expenses | 8,292 | 57,416 | |||||||||||||
accounts payable and accrued expenses | 967,888 | 671,019 | |||||||||||||
proceeds from promissory note – related party | 150,000 | ||||||||||||||
net change in cash | -450,661 | -599,069 | |||||||||||||
cash – beginning of period | 475,339 | 0 | |||||||||||||
cash – end of period | 24,678 | -599,069 | |||||||||||||
level 1: | |||||||||||||||
level 2: | |||||||||||||||
level 3: | |||||||||||||||
transaction costs allocated to warrant issuance | |||||||||||||||
investment of cash in trust account | -2,300,000 | ||||||||||||||
proceeds from sale of units, net of underwriting discounts paid | |||||||||||||||
proceeds from sale of private placements warrants | 2,300,000 | ||||||||||||||
repayment of promissory note— related party | |||||||||||||||
payment of offering costs | |||||||||||||||
non-cash investing and financing activities: | |||||||||||||||
offering costs paid by sponsor in exchange for issuance of founder shares | |||||||||||||||
offering costs paid through promissory note – related party | |||||||||||||||
accretion of class a common stock to possible redemption | |||||||||||||||
deferred underwriting fee payable | |||||||||||||||
change in fair value of warrant liability | |||||||||||||||
interest earned on marketable securities held in trust account | |||||||||||||||
offering costs included in accrued offering costs | |||||||||||||||
offering costs paid through promissory note | |||||||||||||||
change in value of class a common stock subject to possible redemption | |||||||||||||||
redeemable class a common stock | |||||||||||||||
numerator: earnings allocable to redeemable class a common stock | |||||||||||||||
interest income | |||||||||||||||
income and franchise tax | |||||||||||||||
net earnings | |||||||||||||||
denominator: weighted-average redeemable class a common stock | |||||||||||||||
redeemable class a common stock, basic and diluted | |||||||||||||||
earnings/basic and diluted redeemable class a common stock | |||||||||||||||
non-redeemable class b common stock | |||||||||||||||
numerator: net income minus redeemable net earnings | |||||||||||||||
redeemable net earnings | |||||||||||||||
non-redeemable net income | |||||||||||||||
denominator: weighted-average non-redeemable class b common stock | |||||||||||||||
non-redeemable class b common stock, basic and diluted | |||||||||||||||
loss/basic and diluted non-redeemable class b common stock |
We provide you with 20 years of cash flow statements for Eve Air Mobility stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Eve Air Mobility stock. Explore the full financial landscape of Eve Air Mobility stock with our expertly curated income statements.
The information provided in this report about Eve Air Mobility stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.